Product Information
TRANEXAMIC ACID 1,000 MG/10 ML is a generic product labeled by Sagent Pharmaceuticals, priced at $0.4035 per ML under NDC 25021041566. Its NADAC has been published 40 times since Dec 31, 2025.
FDA first approved this application on Feb 13, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021041566
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
TRANEXAMIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA207239FDA Approved
2/13/2017
TE Code
AP
On Market Since
7/15/2023
Pharmacological Classes
Price Statistics
The NADAC for TRANEXAMIC ACID 1,000 MG/10 ML has been published 40 times since Dec 31, 2025, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4035 per ML |
|---|---|
| All-time high | $0.4035 (Sep 30, 2026) |
| All-time low | $0.3481 (Dec 31, 2025) |
| 52-week high | $0.4035 |
| 52-week low | $0.3481 |
| Median price | $0.3575 |
| Average price | $0.3625 |
| Largest weekly change | +5.1% (Jul 22, 2026) |
| Weeks tracked | 40 |
| Tracking since | Dec 31, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tranexamic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antifibrinolytic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRANEXAMIC ACID 1,000 MG/10 ML?
The current National Average Drug Acquisition Cost (NADAC) for TRANEXAMIC ACID 1,000 MG/10 ML, manufactured by Sagent Pharmaceuticals, is $0.4035 per ML (NDC 25021041566), effective Sep 30, 2026.
How has the price of TRANEXAMIC ACID 1,000 MG/10 ML changed over time?
Over the history we have for it, the NADAC for TRANEXAMIC ACID 1,000 MG/10 ML has risen 15.9%. It has been tracked across 40 weekly CMS publications since Dec 31, 2025.
What are the highest and lowest recorded NADAC prices for TRANEXAMIC ACID 1,000 MG/10 ML?
Since Dec 31, 2025, the NADAC for TRANEXAMIC ACID 1,000 MG/10 ML has ranged from a low of $0.3481 (Dec 31, 2025) to a high of $0.4035 (Sep 30, 2026), with a median of $0.3575 per ML.
Are there cheaper alternatives to TRANEXAMIC ACID 1,000 MG/10 ML?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRANEXAMIC ACID 1,000 MG/10 ML, is $0.3481 per ML — about 14% below TRANEXAMIC ACID 1,000 MG/10 ML.
Who manufactures TRANEXAMIC ACID 1,000 MG/10 ML?
TRANEXAMIC ACID 1,000 MG/10 ML (NDC 25021041566) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.